Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2026-04-27 @ 1:17 AM
Study NCT ID:
NCT04530656
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2020-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
Sponsor:
Organization: